Hui Ou Yang
Founder at MingMed Biotechnology Co., Ltd.
Profile
Hui Ou Yang is the founder and Chief Technology Officer of MingMed Biotechnology Co., Ltd., a company founded in 2019.
Dr. Ou Yang holds an MBA from the University of California, Los Angeles, an undergraduate and graduate degree from Peking University Health Science Center, and a doctorate from the University of North Carolina at Chapel Hill.
Hui Ou Yang active positions
| Companies | Position | Start |
|---|---|---|
MingMed Biotechnology Co., Ltd.
 MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China. | Founder | 24/11/2019 |
Training of Hui Ou Yang
| Peking University Health Science Center | Graduate Degree |
| University of North Carolina at Chapel Hill | Doctorate Degree |
| University of California, Los Angeles | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
MingMed Biotechnology Co., Ltd.
MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China. | Health Technology |
- Stock Market
- Insiders
- Hui Ou Yang
